Multi-Omics Characterization of E3 Regulatory Patterns in Different Cancer Types

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Ubiquitination is a critical post-translational modification regulating protein degradation and cellular processes.
• E3 ubiquitin ligases dictate substrate specificity in ubiquitination.
• Dysregulated ubiquitination is implicated in cancer development and progression.

Purpose of the Study:

• To investigate E3 ligase expression patterns across 12 cancer types.
• To characterize E3-substrate regulatory networks using multi-omics data in lung squamous cell carcinoma.
• To identify potential prognostic biomarkers and therapeutic targets in cancer.

Main Methods:

• Analysis of E3 ligase protein expression in tumor and normal tissues.
• Correlation analysis of E3 ligase and substrate protein expression.
• Integration of transcriptome, proteome, and ubiquitylome data for lung squamous cell carcinoma.

Main Results:

• E3 ligases show increased expression and reduced tissue specificity in tumors.
• Altered E3-substrate interactions were observed in cancer.
• Upregulation of SKP2 promotes BRCA2 degradation, enhancing tumor proliferation.
• Upregulation of TRIM33 correlates with favorable prognosis by inhibiting the cell cycle.

Conclusions:

• Multi-omics analysis of E3 ligases reveals altered regulatory patterns in cancer.
• E3 ligases like TRIM33 can serve as prognostic biomarkers.
• Understanding E3 ligase function offers opportunities for novel cancer therapies.